HQH · Insider Trading
abrdn Healthcare Investors
Every open-market purchase and sale reported by HQH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-07 | Alan R Goodson | Director | Sell | −242 | −$4.68K |
| 2026-07-20 | Chris LaVictoire Mahai | Director | Buy | +501 | +$10.50K |
| 2024-07-18 | Rose DiMartino | Director | Buy | +1,000 | +$18.88K |
| 2024-04-12 | Kathleen Goetz | Director | Buy | +525 | +$8.62K |
| 2024-01-09 | Alan R Goodson | Vice President | Buy | +170 | +$2.74K |
| 2024-01-04 | Todd Reit | Director | Buy | +1,000 | +$16.93K |
| 2024-01-02 | Bill Maher | Director | Buy | +1,000 | +$16.58K |
| 2023-09-25 | Daniel R Omstead | President | Buy | +9,500 | +$148.52K |
| 2023-09-20 | Daniel R Omstead | President | Buy | +9,500 | +$150.83K |
| 2022-03-24 | Kathleen Goetz | Director | Buy | +73 | +$1.50K |
| 2022-01-27 | Kathleen Goetz | Director | Buy | +481 | +$10.35K |
| 2020-10-26 | Daniel R Omstead | President | Buy | +5,200 | +$106.74K |
| 2020-10-21 | Daniel R Omstead | President | Buy | +5,050 | +$104.43K |
| 2020-09-23 | Jeffrey Allen Bailey | Director | Buy | +490 | +$9.99K |
| 2020-05-22 | Daniel R Omstead | President | Buy | +5,000 | +$105.05K |
| 2020-03-17 | Daniel R Omstead | President | Buy | +6,800 | +$110.41K |
| 2018-12-26 | Daniel R Omstead | President | Buy | +6,300 | +$107.97K |
| 2018-10-25 | Daniel R Omstead | President | Buy | +5,500 | +$112.34K |
| 2018-10-17 | Daniel R Omstead | President | Buy | +3,882 | +$84.53K |
| 2018-01-29 | Thomas M Kent | Director | Buy | +1,100 | +$26.60K |
| 2016-01-07 | Timothy L Gasperoni | — | Buy | +862 | +$24.98K |
| 2015-06-29 | Lucinda H Stebbins | Director | Buy | −2,000 | −$71.48K |
| 2014-07-11 | Uwe E Reinhardt | Director | X | +745 | +$18.65K |
| 2014-07-01 | Daniel R Omstead | President | X | +11,944 | +$299.04K |
| 2013-06-04 | Daniel R Omstead | President | Buy | +5,000 | +$107.26K |
| 2012-03-21 | Oleg M Pohotsky | Director | Buy | +200 | +$3.20K |
| 2012-03-12 | Michael W Bonney | Director | Buy | +650 | +$10.27K |
| 2012-03-12 | William S Reardon | Director | Buy | +646 | +$10.24K |
| 2011-08-08 | Daniel R Omstead | President | Buy | +8,100 | +$100.22K |
| 2009-09-11 | Lucinda H Stebbins | Director | Buy | +1,000 | +$10.51K |
| 2009-08-06 | Daniel R Omstead | President | Buy | +3,000 | +$32.10K |
| 2008-12-01 | Daniel R Omstead | President | Buy | +2,000 | +$17.94K |
| 2008-10-14 | Daniel R Omstead | President | Buy | +387 | +$4.41K |
| 2007-11-26 | Daniel R Omstead | President | Buy | +1,500 | +$23.73K |
| 2007-10-04 | Daniel R Omstead | President | Buy | +1,500 | +$26.10K |
| 2007-08-22 | Lucinda H Stebbins | Director | Buy | +1,000 | +$16.63K |
| 2007-08-06 | Daniel R Omstead | President | Buy | +1,000 | +$16.79K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Chris LaVictoire Mahai | Director | 501 | $10.21K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HQH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.